DK0981377T3 - Komplekser af LHRH-antagonisten Cetrorelix med polyaminosyrer og fremgangsmåder til deres fremstilling - Google Patents

Komplekser af LHRH-antagonisten Cetrorelix med polyaminosyrer og fremgangsmåder til deres fremstilling

Info

Publication number
DK0981377T3
DK0981377T3 DK98914877T DK98914877T DK0981377T3 DK 0981377 T3 DK0981377 T3 DK 0981377T3 DK 98914877 T DK98914877 T DK 98914877T DK 98914877 T DK98914877 T DK 98914877T DK 0981377 T3 DK0981377 T3 DK 0981377T3
Authority
DK
Denmark
Prior art keywords
complexes
preparation
methods
polyamino acids
lhrh antagonist
Prior art date
Application number
DK98914877T
Other languages
English (en)
Inventor
Thomas Reissmann
Juergen Engel
Wolfgang Deger
Guenter Losse
Wolfgang Naumann
Sandra Murgas
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Application granted granted Critical
Publication of DK0981377T3 publication Critical patent/DK0981377T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK98914877T 1997-03-26 1998-03-11 Komplekser af LHRH-antagonisten Cetrorelix med polyaminosyrer og fremgangsmåder til deres fremstilling DK0981377T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19712718A DE19712718C2 (de) 1997-03-26 1997-03-26 Immobilisierte und aktivitätsstabilisierte Komplexe von LHRH-Antagonisten und Verfahren zu deren Herstellung
PCT/EP1998/001398 WO1998042381A1 (de) 1997-03-26 1998-03-11 Immobilisierte und aktivitätsstabilisierte komplexe von lhrh-antagonisten und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
DK0981377T3 true DK0981377T3 (da) 2003-11-10

Family

ID=7824698

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98914877T DK0981377T3 (da) 1997-03-26 1998-03-11 Komplekser af LHRH-antagonisten Cetrorelix med polyaminosyrer og fremgangsmåder til deres fremstilling

Country Status (27)

Country Link
US (2) US6022860A (da)
EP (1) EP0981377B1 (da)
JP (1) JP4180120B2 (da)
CN (1) CN1150943C (da)
AR (1) AR012186A1 (da)
AT (1) ATE249245T1 (da)
AU (1) AU747808B2 (da)
BR (1) BR9807887B1 (da)
CA (1) CA2285054C (da)
CZ (1) CZ300755B6 (da)
DE (2) DE19712718C2 (da)
DK (1) DK0981377T3 (da)
ES (1) ES2206912T3 (da)
HK (1) HK1025255A1 (da)
HU (1) HUP0002059A3 (da)
IL (1) IL131181A (da)
NO (1) NO327404B1 (da)
NZ (1) NZ337343A (da)
PL (1) PL190090B1 (da)
PT (1) PT981377E (da)
RU (1) RU2207151C2 (da)
SK (1) SK284461B6 (da)
TR (1) TR199902168T2 (da)
TW (1) TW520288B (da)
UA (1) UA69381C2 (da)
WO (1) WO1998042381A1 (da)
ZA (1) ZA982225B (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
EP0788799A3 (en) * 1996-02-07 1998-10-21 ASTA Medica Aktiengesellschaft LHRH-Antagonists in the treatment of fertility disorders
US5968895A (en) 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US20070185032A1 (en) * 1996-12-11 2007-08-09 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
EP1082129B1 (en) * 1998-04-23 2003-10-29 Zentaris AG Method for the treatment of fertility disorders
CO5160256A1 (es) * 1999-02-08 2002-05-30 Zentaris Ag Sales de peptidos farmaceuticamente activos para la liberacion sostenida y proceso de produccion
DE10024451A1 (de) 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
WO2002022154A2 (en) * 2000-09-13 2002-03-21 Praecis Pharmaceuticals Incorporated Pharmaceutical compositions for sustained drug delivery
PE20020908A1 (es) * 2001-03-21 2002-10-26 Cell Therapeutics Inc Produccion recombinante de polimeros polianionicos y uso de de los mismos
US7015253B2 (en) * 2001-07-10 2006-03-21 American Medical Systems, Inc. Regimen for treating prostate tissue and surgical kit for use in the regimen
US7214662B2 (en) 2001-11-27 2007-05-08 Zentaris Gmbh Injectable solution of an LHRH antagonist
US8093207B2 (en) * 2005-12-09 2012-01-10 Unigene Laboratories, Inc. Fast-acting oral peptide pharmaceutical products
US9232959B2 (en) 2007-01-02 2016-01-12 Aquabeam, Llc Multi fluid tissue resection methods and devices
US20220096112A1 (en) 2007-01-02 2022-03-31 Aquabeam, Llc Tissue resection with pressure sensing
ES2858596T3 (es) 2007-01-02 2021-09-30 Aquabeam Llc Dispositivos mínimamente invasivos para el tratamiento de enfermedades de la próstata
ES2769535T3 (es) 2008-03-06 2020-06-26 Aquabeam Llc Ablación de tejido y cauterización con energía óptica transportada en una corriente de fluido
US10524822B2 (en) 2009-03-06 2020-01-07 Procept Biorobotics Corporation Image-guided eye surgery apparatus
US9848904B2 (en) 2009-03-06 2017-12-26 Procept Biorobotics Corporation Tissue resection and treatment with shedding pulses
JP5522486B2 (ja) * 2009-03-27 2014-06-18 国立大学法人 鹿児島大学 疎水化ポリアミノ酸からなるポリイオンコンプレックスとその用途
CN104203078B (zh) 2012-02-29 2018-04-20 普罗赛普特生物机器人公司 自动化图像引导的组织切除和处理
BR112016005036A2 (pt) 2013-09-06 2020-04-07 Procept Biorobotics Corp aparelho para ressecção de tecido guiada por imagem automatizada
JP6651471B2 (ja) 2014-06-30 2020-02-19 プロセプト バイオロボティクス コーポレイション 流体ジェット組織アブレーションおよび冷凝固（ａｑｕａｂｌａｔｉｏｎ）方法および装置
JP2017532095A (ja) 2014-09-05 2017-11-02 プロセプト バイオロボティクス コーポレイション 標的器官画像の処理マッピングと一体化された医師制御組織切除

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE257197C (da) *
US4341767A (en) * 1980-10-06 1982-07-27 Syntex Inc. Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists
DD257197A1 (de) * 1987-01-28 1988-06-08 Univ Dresden Tech Verfahren zur herstellung von immobilisierten, in ihrer biologischen aktivitaet stabilisierten und in ihren pharmakologischen eigenschaften modifizierten insulinpraeparationen
US4801577A (en) * 1987-02-05 1989-01-31 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
DD269785A1 (de) * 1988-02-08 1989-07-12 Univ Dresden Tech Verfahren zur herstellung von aktivitaetsstabilisierten und in ihren pharmakologischen eigenschaften modifizierten peptidderivaten
DD273980B5 (de) * 1988-07-12 1994-04-14 Berlin Chemie Ag Verfahren zur Herstellung von Insulin-Pr{paraten zur rektalen Anwendung
DE59107006D1 (de) * 1990-04-25 1996-01-18 Hoechst Ag Pharmakologische Zubereitung, enthaltend Polyelektrolytkomplexe in mikropartikulärer Form und mindestens einen Wirkstoff.
DD299265A5 (de) * 1990-09-11 1992-04-09 Technische Universitaet Dresden,De Verfahren zur herstellung von immobilisierten und aktivitaetsstabilisierten praeparaten des gonadotropin-releasing-hormons oder dessen analoga mit polyaminosaeuren
US5834520A (en) * 1992-10-08 1998-11-10 Asta-Medica Aktiengesellschaft Container for injectable mesna solutions
EP0670728A4 (en) * 1992-11-12 1996-04-17 Molecular Dynamics Inc PIPTIDE-BASED LIPOPHILE-BASED CARRIERS FOR TARGETED MEDICINE ADMINISTRATION USING A RATIONAL MEDICINE-BINDING DESIGN.
DE4305225A1 (de) * 1993-02-19 1994-08-25 Asta Medica Ag Neues Herstellverfahren für Cetrorelix Lyophilisat
US5449720A (en) * 1993-05-24 1995-09-12 Biotech Australia Pty Limited Amplification of the VB12 uptake system using polymers
US5502035A (en) * 1993-08-06 1996-03-26 Tap Holdings Inc. N-terminus modified analogs of LHRH
CA2178592C (en) * 1993-12-09 2009-07-28 Jurgen Engel Long-acting injection suspensions and a process for their preparation
US5821230A (en) * 1997-04-11 1998-10-13 Ferring Bv GnRH antagonist decapeptides

Also Published As

Publication number Publication date
CA2285054A1 (en) 1998-10-01
PT981377E (pt) 2004-02-27
CA2285054C (en) 2007-08-21
JP2001520662A (ja) 2001-10-30
DE19712718A1 (de) 1998-10-01
HUP0002059A3 (en) 2001-02-28
EP0981377B1 (de) 2003-09-10
HUP0002059A2 (hu) 2000-10-28
CN1150943C (zh) 2004-05-26
NZ337343A (en) 2001-10-26
NO327404B1 (no) 2009-06-22
NO994665D0 (no) 1999-09-24
AU747808B2 (en) 2002-05-23
SK131699A3 (en) 2000-05-16
BR9807887B1 (pt) 2010-05-18
ZA982225B (en) 1998-04-03
AR012186A1 (es) 2000-09-27
CN1249691A (zh) 2000-04-05
IL131181A0 (en) 2001-01-28
JP4180120B2 (ja) 2008-11-12
AU6920798A (en) 1998-10-20
RU2207151C2 (ru) 2003-06-27
US6054555A (en) 2000-04-25
CZ300755B6 (cs) 2009-08-05
TR199902168T2 (xx) 1999-12-21
DE59809575D1 (de) 2003-10-16
TW520288B (en) 2003-02-11
DE19712718C2 (de) 1999-09-23
HK1025255A1 (en) 2000-11-10
IL131181A (en) 2004-09-27
ES2206912T3 (es) 2004-05-16
PL335830A1 (en) 2000-05-22
WO1998042381A1 (de) 1998-10-01
PL190090B1 (pl) 2005-10-31
CZ337199A3 (cs) 2000-03-15
ATE249245T1 (de) 2003-09-15
BR9807887A (pt) 2000-02-22
UA69381C2 (uk) 2004-09-15
US6022860A (en) 2000-02-08
SK284461B6 (sk) 2005-04-01
EP0981377A1 (de) 2000-03-01
NO994665L (no) 1999-09-24

Similar Documents

Publication Publication Date Title
DK0981377T3 (da) Komplekser af LHRH-antagonisten Cetrorelix med polyaminosyrer og fremgangsmåder til deres fremstilling
IS2321B (is) Aðferðir og blöndur til að fyrirbyggja þol gegn berkjuvíkkandi lyfjum
DK0927192T3 (da) Modificerede aminosyrer, lægemidler indeholdende disse forbindelser og fremgangsmåder til deres fremstilling
DE69704712D1 (de) Tablette mit gesteuerter freisetzung von alfuzosinhydrochlorid
DK0984773T3 (da) Farmaceutisk formulering med omeprazol
NO20003067D0 (no) Antipicornavirus-forbindelser og fremgangsmÕter for deres anvendelse og fremstilling
NO942193D0 (no) Metallocener og fremgangsmåte til deres fremstilling og bruk
DK0980240T3 (da) Sammensætninger med lang frigivelse og fremgangsmåde til fremstilling heraf
DK0797991T3 (da) Lægemiddelformulering med forhalet frigivelse
DK1015444T3 (da) Pyrimidinderivater og fremgangsmåder til fremstilling deraf
DK1066049T3 (da) Farmaceutiske præparater, der er beregnet til langvarig frigivelse af peptider og fremgangsmåde til fremstilling af disse
FI103614B1 (fi) Vaiheistus- ja balansointielin
IS6183A (is) Díamínóþíazol og notagildi þeirra til að hindra prótín kínasa
NO984082D0 (no) Pyrimido£5,4-d|pyrimidiner, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmÕte for fremstilling derav
NO20001323D0 (no) Dipeptid-apoptose inhibitorer og deres anvendelse
DK1019358T4 (da) 3,3-diarylpropylaminer, deres anvendelse og fremstilling
DK0931081T3 (da) Pyridazino-[4,5-B]-quinolin-5-oxid-derivater, deres fremstilling og deres anvendelse som glycinantagonister
FI980246A0 (fi) Menetelmä keittimen käyttämiseksi ja keitin
DK1021200T3 (da) Fremgangsmåder og præparater til behandling af rheumatoid arthritis
DK0905128T3 (da) Fremgangsmåder og mellemprodukter egnede til fremstilling af antifolater
NO994161D0 (no) 7-[(piperidin-1-yl)-propoksy]-kromen-4-onderivater, deres fremstilling og deres farmasöytiske anvendelse
DE69802131D1 (de) Humane Protein-Kinase hYAK3
FI974544A0 (fi) Anordning i en med manoeverplats foersedd lastkran
FI974235A0 (fi) Ny bestaemningsmetod
NO20003606L (no) Triazepinoner, fremgangsmÕte for deres fremstilling, samt deres terapeutiske anvendelse